Target intelligence / Profile preview

Polycystic kidney disease 1 (autosomal dominant) pseudogene 3 (PKD1P3)

Target: PKD1P3
Molecular classification: Pseudogene, Other

Overview

PKD1P3 (polycystic kidney disease 1 [autosomal dominant] pseudogene 3) is a human pseudogene found on chromosome 16 in a duplicated region that shares high sequence homology with the gene PKD1. PKD1P3 is unprocessed and does not code for a functional protein. Its primary relevance is in clinical genetics, where sequence similarity with PKD1 can complicate the molecular diagnosis of autosomal dominant polycystic kidney disease (ADPKD). Gene conversion or recombination events between PKD1 and PKD1P3 can introduce variants into the PKD1 gene, occasionally leading to pathogenic changes identified in ADPKD patients. PKD1P3 is not a therapeutic target, receptor, or enzyme, and has no known biological function or drug interactions.

Other names: HG3PKD1P3Polycystin 1, transient receptor potential channel interacting pseudogene 3polycystic kidney disease 1 (autosomal dominant) pseudogene 3

Mechanism of action

null (no molecular function or drug mechanism applies to PKD1P3)

Biological functions

Null (no protein product or direct biological function known; not involved in cellular or molecular pathways in a canonical sense)

Disease associations

Other (PKD1P3 itself is not causative, but gene conversion events involving PKD1P3 and the functional PKD1 gene have been implicated in the genetics of autosomal dominant polycystic kidney disease (ADPKD))

Safety considerations

null (as a pseudogene, no direct safety or therapeutic concerns; indirect challenges include misalignment or sequencing errors impacting the genuine PKD1 gene during diagnostics due to high sequence homology)

Biomarkers

null (PKD1P3 is not used directly as a biomarker, but conversion or mutation events involving PKD1P3 and PKD1 may be identified in genetic diagnostics related to ADPKD)

Beyond the preview

Go deeper on Polycystic kidney disease 1 (autosomal dominant) pseudogene 3 (PKD1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polycystic kidney disease 1 (autosomal dominant) pseudogene 3 (PKD1P3).

Explore the full profile